91 related articles for article (PubMed ID: 12215248)
21. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
22. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.
Metcalfe KA; Poll A; Llacuachaqui M; Nanda S; Tulman A; Mian N; Sun P; Narod SA
Clin Genet; 2010 Nov; 78(5):411-7. PubMed ID: 20653694
[TBL] [Abstract][Full Text] [Related]
23. Assessing the knowledge and attitudes regarding genetic testing for breast cancer risk in our region of southeastern Georgia.
MacNew HG; Rudolph R; Brower ST; Beck AN; Meister EA
Breast J; 2010; 16(2):189-92. PubMed ID: 20030654
[TBL] [Abstract][Full Text] [Related]
24. Interest in BRCA1/2 testing in a primary care population.
Armstrong K; Weber B; Ubel PA; Guerra C; Schwartz JS
Prev Med; 2002 Jun; 34(6):590-5. PubMed ID: 12052018
[TBL] [Abstract][Full Text] [Related]
25. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
26. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
[TBL] [Abstract][Full Text] [Related]
27. Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Trivers KF; Baldwin LM; Miller JW; Matthews B; Andrilla CH; Lishner DM; Goff BA
Cancer; 2011 Dec; 117(23):5334-43. PubMed ID: 21792861
[TBL] [Abstract][Full Text] [Related]
28. Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).
Juan AS; Wakefield CE; Kasparian NA; Kirk J; Tyler J; Tucker K
Genet Test; 2008 Dec; 12(4):523-32. PubMed ID: 19072564
[TBL] [Abstract][Full Text] [Related]
29. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
[TBL] [Abstract][Full Text] [Related]
30. Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer.
Peters N; Domchek SM; Rose A; Polis R; Stopfer J; Armstrong K
Genet Test; 2005; 9(1):48-53. PubMed ID: 15857187
[TBL] [Abstract][Full Text] [Related]
31. Risk management options elected by women after testing positive for a BRCA mutation.
Garcia C; Wendt J; Lyon L; Jones J; Littell RD; Armstrong MA; Raine-Bennett T; Powell CB
Gynecol Oncol; 2014 Feb; 132(2):428-33. PubMed ID: 24355485
[TBL] [Abstract][Full Text] [Related]
32. Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians.
Peshkin BN; Isaacs C; Finch C; Kent S; Schwartz MD
J Clin Oncol; 2003 Dec; 21(23):4322-8. PubMed ID: 14645421
[TBL] [Abstract][Full Text] [Related]
33. Recruitment, genetic counseling, and BRCA testing for underserved women at a public hospital.
Lee R; Beattie M; Crawford B; Mak J; Stewart N; Komaromy M; Esserman L; Shaw L; McLennan J; Strachowski L; Luce J; Ziegler J
Genet Test; 2005; 9(4):306-12. PubMed ID: 16379544
[TBL] [Abstract][Full Text] [Related]
34. BRCA 1/2-negative patients who receive counseling after genetic testing have lower anxiety.
Printz C
Cancer; 2016 Apr; 122(8):1149. PubMed ID: 27061519
[No Abstract] [Full Text] [Related]
35. Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.
Gray SW; O'Grady C; Karp L; Smith D; Schwartz JS; Hornik RC; Armstrong K
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1303-11. PubMed ID: 19318436
[TBL] [Abstract][Full Text] [Related]
36. Information-seeking behaviour and psycho-social interactions during the genetic testing process.
Cypowyj C; Eisinger F; Morin M; Mogoutov A; Sobol H; Julian-Reynier C
Community Genet; 2003; 6(4):224-34. PubMed ID: 15331868
[TBL] [Abstract][Full Text] [Related]
37. Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system.
Bellcross CA; Peipins LA; McCarty FA; Rodriguez JL; Hawkins NA; Hensley Alford S; Leadbetter S
Genet Med; 2015 Jan; 17(1):43-50. PubMed ID: 24946155
[TBL] [Abstract][Full Text] [Related]
38. Genetic risk assessment and BRCA mutation testing.
Ormond KE; Bellcross C; Weissman S
Ann Intern Med; 2006 Feb; 144(4):303-4; discussion 304. PubMed ID: 16490919
[No Abstract] [Full Text] [Related]
39. Intrafamilial communication of hereditary breast and ovarian cancer genetic information in Italian women: towards a personalised approach.
Di Pietro ML; Zaçe D; Orfino A; Di Raimo FR; Poscia A; de Matteis E; Turchetti D; Godino L; Bertonazzi B; Franiuk M; Bruzzone C; Varesco L; Lucci-Cordisco E; Genuardi M
Eur J Hum Genet; 2021 Feb; 29(2):250-261. PubMed ID: 32929237
[TBL] [Abstract][Full Text] [Related]
40. Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
Staudigl C; Pfeiler G; Hrauda K; Renz R; Berger A; Lichtenschopf R; Singer CF; Tea MK
BMC Cancer; 2016 Jul; 16():436. PubMed ID: 27391110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
